leadf
logo-loader
OTCQB:GTBP

GT Biopharma Inc.

Receive alerts
Market:
OTCQB
Market Cap:
$40.61 m
Price
0.49 USD
Change
-4.88%
52 weeks high
0.77
52 weeks low
0.08

In brief

We are a clinical stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products and a portfolio of central nervous system, or CNS, product candidates. Our immuno-oncology portfolio is based off a proprietary technology platform consisting of single-chain bi-, tri- and tetra-specific scFv constructs, combined with proprietary antibody-drug linkers and drug payloads. Our CNS portfolio consists of innovative reformulations and/or repurposing of existing therapies that are covered by issued or filed composition of matter patents.